Novo Nordisk
NVO
NVO
482 hedge funds and large institutions have $5.6B invested in Novo Nordisk in 2016 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 121 increasing their positions, 212 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
43% less funds holding in top 10
Funds holding in top 10: 14 → 8 (-6)
43% less repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 212
59% less call options, than puts
Call options by funds: $13.1M | Put options by funds: $31.9M
Holders
482
Holding in Top 10
8
Calls
$13.1M
Puts
$31.9M
Top Buyers
| 1 | +$139M | |
| 2 | +$95.6M | |
| 3 | +$57.6M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$30.1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$27.2M |
Top Sellers
| 1 | -$332M | |
| 2 | -$276M | |
| 3 | -$267M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$105M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$90.5M |